Patients Deserve Accurate Drug Pricing Data
House Committee on Energy and Commerce · February 18, 2026
An unidentified witness testified that actors across the prescription drug supply chain blame one another for high prices and that congressional, employer and patient access to transactional-level price data is lacking, preventing accountability for rising costs.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.